The combination of sarcopenia and biochemical factors can predict the survival of hepatocellular carcinoma patients receiving transarterial chemoembolization

Overview of attention for article published in Frontiers in oncology, September 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 25,784 followers.

RT @DrImranSheikh: The combination of sarcopenia and biochemical factors can predict the survival of hepatocellular carcinoma patients rece…

29 Sep 2022

Reply Repost Favourite

The combination of sarcopenia and biochemical factors can predict the survival of hepatocellular carcinoma patients receiving transarterial chemoembolization: Background, Transarterial chemoembolization(TACE) is the suggested… #oncology https://t.co/5savu

29 Sep 2022

Reply Repost Favourite

New research: The combination of sarcopenia and biochemical factors can predict the survival of hepatocellular carcinoma patients receiving transarterial chemoembolization: Background Transarterial chemoembolization(TACE) is the suggested… https://t.co/1R

29 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.